Aprea Therapeutics (APRE) Filings

4

APRE Aprea Therapeutics Inc

13 Mar 23

Aprea Therapeutics / Oren Gilad ownership change

6:30pm

8-K

APRE Aprea Therapeutics Inc

13 Mar 23

Regulation FD Disclosure

6:02am

SC 13G

APRE Aprea Therapeutics Inc

3 Mar 23

Aprea Therapeutics / HIRSCHMAN ORIN ownership change

6:03am

8-K

APRE Aprea Therapeutics Inc

1 Mar 23

Other Events

5:16pm

4

APRE Aprea Therapeutics Inc

27 Feb 23

Aprea Therapeutics / John P. Hamill ownership change

6:37pm

8-K

APRE Aprea Therapeutics Inc

24 Feb 23

Aprea Therapeutics Announces Proposed Public Offering of Common Stock

5:25pm

424B5

APRE Aprea Therapeutics Inc

24 Feb 23

Prospectus supplement for primary offering

5:21pm

424B5

APRE Aprea Therapeutics Inc

22 Feb 23

Prospectus supplement for primary offering

4:25pm

8-K

APRE Aprea Therapeutics Inc

13 Feb 23

Other Events

5:34pm

8-K

APRE Aprea Therapeutics Inc

13 Feb 23

Aprea Therapeutics Announces One-for-Twenty Reverse Stock Split

7:08am

8-K

APRE Aprea Therapeutics Inc

10 Feb 23

Other Events

4:31pm

4

Hamill John P.

30 Jan 23

Aprea Therapeutics / John P. Hamill ownership change

5:21pm

3

APRE Aprea Therapeutics Inc

30 Jan 23

Aprea Therapeutics / John P. Hamill ownership change

5:19pm

8-K

APRE Aprea Therapeutics Inc

30 Jan 23

Aprea Therapeutics Appoints John Hamill as Chief Financial Officer

4:45pm

8-K

APRE Aprea Therapeutics Inc

26 Jan 23

Other Events

8:00am

8-K

APRE Aprea Therapeutics Inc

9 Jan 23

Other Events

8:00am

S-8

APRE Aprea Therapeutics Inc

15 Dec 22

Registration of securities for employees

5:00pm

8-K

APRE Aprea Therapeutics Inc

17 Nov 22

Submission of Matters to a Vote of Security Holders

4:30pm

8-K

APRE Aprea Therapeutics Inc

16 Nov 22

Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard

4:29pm

SC 13D/A

APRE Aprea Therapeutics Inc

15 Nov 22

Aprea Therapeutics / HealthCap VII ownership change

5:08pm